Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of hybridoma cell and the monoclonal antibody it produces and application

A hybridoma cell, monoclonal antibody technology, applied in the field of monoclonal antibodies, to achieve the effect of inhibiting thrombosis and inhibiting coagulation reaction

Inactive Publication Date: 2017-02-01
SUZHOU UNIV
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are currently few studies on the prevention and treatment of members of the protein disulfide isomerase (PDI) family for the prevention and treatment of thrombotic diseases and disseminated intravascular coagulation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of hybridoma cell and the monoclonal antibody it produces and application
  • A kind of hybridoma cell and the monoclonal antibody it produces and application
  • A kind of hybridoma cell and the monoclonal antibody it produces and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Example 1: Preparation of Monoclonal Antibody Hybridoma Cells

[0042] 1. Materials

[0043] Antigen: protein with the amino acid sequence shown in SEQ ID NO:1, fully synthesized by the reagent company;

[0044] Test animals: 8-10 weeks old, about 17g BALB / C mice;

[0045] Reagents: Freund's complete adjuvant and incomplete adjuvant (purchased from Promega);

[0046] Myeloma cells: SP2 / 0 cells (provided by China Center for Type Culture Collection);

[0047] Medium: HAT selective medium (purchased from Sigma);

[0048] 2. Method

[0049] Get 100 μg of the protein with the amino acid sequence shown in SEQ ID NO:1 and add equal mass Freund's complete adjuvant to carry out the first subcutaneous injection to BALB / C mice, take the protein 300 μg with the amino acid sequence shown in SEQ ID NO:1 after 21 days, add The same mass of Freund's incomplete adjuvant was used to subcutaneously inject BALB / C mice for the second time, and after 10 days, the tail blood was collecte...

Embodiment 2

[0051] Example 2: Secretion produces DuIn antibody

[0052] After immunizing BALB / C mice with incomplete adjuvant for 1 to 2 weeks, intraperitoneally inject 1×10 6 A hybridoma cell with a preservation number of CGMCC NO.9153, which produces ascites 7 to 10 days after inoculation of the hybridoma cell;

[0053] Extract the ascites from the peritoneal cavity of the BALB / C mouse, put it in a 15ml centrifuge tube, centrifuge at 2000rpm for 10min to precipitate blood cells and other impurities, transfer the supernatant into a new centrifuge tube, store it in a -80°C refrigerator, and purify Before, use 0.1M PBS solution to dilute ascites at a ratio of 1:3;

[0054] Take 0.5ml Protein G and load it into the adsorption column, add 20 times the column volume of 0.1M PBS buffer to equilibrate the column for sample loading;

[0055] Take the diluted ascites, add it to the purification column, 2-3ml each time, and circulate the ascites through the column for 3 times;

[0056] After th...

Embodiment 3

[0059] Embodiment 3: DuIn antibody specific detection

[0060] Take ERp57fl / fl (control mouse, the gene encoding the amino acid sequence protein shown in SEQ ID NO: 1) and PF4-Cre / ERp57fl / fl (platelet-specific knockout of the amino acid sequence shown in SEQ ID NO: 1) Protein coding gene mouse) platelet lysate 200 μg and ERp57 recombinant protein 50ng were subjected to polyacrylamide gel electrophoresis, and then the protein was transferred to PVDF membrane and blocked with 5% skimmed milk solution at room temperature for 1 hour. Use TBS / T solution to dilute the anti-DuIn antibody to 1 μg / ml, put the blocked PVDF membrane into the antibody diluent, and incubate at room temperature for 2 hours. After the incubation, wash with TBS / T solution 3 times, 10 minutes each time, then add the membrane to the fluorescently labeled secondary antibody dilution solution, and incubate at room temperature for 1 hour. After 1 hour, wash the membrane 3 times with TBS / T solution, use Odyssey in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of biotechnology and discloses a hybridoma cell, a monoclonal antibody generated by the hybridoma cell and application of the monoclonal antibody. The collection number of the hybridoma cell is CGMCC (China General Microbiological Culture Collection Center) NO.9153. The hybridoma cell and the monoclonal antibody secreted by the hybridoma cell are prepared from a member of the optimized PDI (protein disulfide isomerase) protein family as antigen protein; the hybridoma cell can stably generate the monoclonal antibody resistant to protein with an amino acid sequence as shown in SEQ ID NO:1; the monoclonal antibody has a two-way inhibition function, can inhibit thrombogenesis and blood clotting reaction, and can be applied to preparation of drugs for treating thrombotic diseases and clotting diseases.

Description

technical field [0001] The invention relates to the field of biotechnology, in particular to a hybridoma cell, a monoclonal antibody produced therefrom and applications thereof. Background technique [0002] Thrombus refers to a semi-clot-like substance formed on the surface of blood vessels or the intima of the heart during blood flow. A thrombus consists of insoluble fibrin, deposited platelets, accumulated white blood cells, and trapped red blood cells. Thrombosis is a multifactorial process involving many interacting genetic and environmental factors. Thrombotic diseases, such as coronary syndrome and deep vein thrombosis, are common clinically. Thrombotic disease belongs to cardiovascular and cerebrovascular diseases. The number of deaths due to cardiovascular and cerebrovascular diseases in the world reaches 12 million every year, which is equivalent to 1 / 4 of the total death toll in the world. It has become the number one killer of human life. [0003] Disseminated...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N5/20C07K16/40A61K39/395A61P7/02C12R1/91
Inventor 武艺周俊松陈凤梧
Owner SUZHOU UNIV